AI Can Help Boost Confidence In Cancer Care Among Clinicians And Patients Alike
Cancer care is a multifaceted and ever-evolving space. And, while the ongoing evolution and new technologies in cancer care a [...]
Dr. Rana McKay on the benefits of the ArteraAI Prostate Test
In this video, Rana R. McKay, MD, discusses the benefits of ArteraAI in prostate cancer. McKay is a medical oncologist and as [...]
Balancing Innovation and the Ethical Adoption of AI in Healthcare
In recent years, the rapid advancement of artificial intelligence (AI) has created a wave of excitement and anticipation with [...]
Unlocking the power of health care AI tools through clinical validation
Artificial intelligence (AI) has emerged as a game-changing technology with the potential to revolutionize health care. Speci [...]
AI-Derived Model Identifies Prostate Cancer Patients Likely to Benefit From ADT
An artificial intelligence (AI)-derived model can identify prostate cancer patients who are likely to benefit from short-term [...]
AI May Predict Benefit with Hormone Therapy Plus Radiotherapy in Prostate Cancer
Artificial intelligence (AI) may predict which patients with intermediate-risk prostate cancer will benefit from short-term a [...]
Novel AI Model Predicts ADT Benefit in Patients With Prostate Cancer
Results of a phase 3 randomized trial published in NEJM Evidence suggest a novel artificial intelligence (AI) model may help [...]
ArteraAI Announces First-Ever AI-Derived Biomarker for Predicting Androgen Deprivation Therapy (ADT) Benefit in Prostate Cancer
ArteraAI, the developer of multimodal artificial intelligence-based predictive and prognostic cancer tests, announced today t [...]
Florida medical tech company launches novel AI test for prostate cancer therapy
ArteraAI’s ‘first-ever predictive test’ helps doctors choose personalized treatment for patients Fox News Article